Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
No correction vs new anthropometric formula for target-controlled infusion of remifentanil in obese patients
2007-007927-42Phase 4Completed
- Sponsor
- AOU Policlinico di Modena
- Start
- Jan 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remifentanil in obesity (2 arms), sponsored by AOU Policlinico di Modena. Primary endpoint: Safety of remifentanil dosing with corrected anthropometric formula. Started Jan 2008; status: completed.
02
Drugs
remifentanil
03
Conditions
obesity
Beyond the preview
Go deeper on 2007-007927-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007927-42.